Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way!

We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed recently.

On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as an investor. He stressed the importance of saving consistently, regardless of any excuses. According to Cramer, starting early is ideal, but even if that is not possible, it is still essential to set aside money for the future.

READ ALSO: 21 Stocks on Jim Cramer’s Radar and Jim Cramer’s Thoughts on These 13 Stocks

He advised that even if someone cannot afford to build a large stock portfolio, it is still worthwhile to invest in as little as possible. One way to do this, he suggested, is by contributing to an index fund or a major mutual fund with whatever money is available.

“If you don’t have enough money or the time to own a stock portfolio, you can only own one or two stocks, send the money in, as little money as you can, to an index fund, to one of these big mutual funds.”

Cramer also noted that if one is planning to pick individual stocks and dealing with real money, they should open an actual investment account. He compared investing to swinging at a pitch; if you know what you’re doing, it can be profitable, but if you do not, the risks are much higher. He warned against treating investing like a gamble or chasing after excitement, as this can lead to poor decisions. Instead, he emphasized the importance of discipline in investing and urged investors not to let their losses accumulate over time.

“So here’s the bottom line: You want to get started, go small, invest what you know, research intensely, just research, research, research… It’s as simple as a keystroke and the information’s free, including up-to-the-minute financials, analyst presentations, brokerage research, and of course, the conference calls that I tell you are a must if you want to actually know what you’re doing. Simple? No. Lucrative? You bet it is.”

Our Methodology

For this article, we compiled a list of 7 stocks that were discussed by Jim Cramer during the episodes of Mad Money aired on May 2. We listed the stocks in ascending order of their hedge fund sentiment as of the fourth quarter of 2024, which was taken from Insider Monkey’s database of over 1,000 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 66

A caller asked why Abbott Laboratories’ (NYSE:ABT) forward PE was higher than its current and trailing PE. Here’s what Cramer had to say in response:

“Okay, their forward PE shows that there’s going to be a, pretty much of an earnings explosion. And I think a lot of that’s going to be coming from Libre, which is their diabetes, they have the best diabetes device. It’s cheaper than everybody’s.

By the way, I think pound for pound, it’s better than Dexcom, and Dexcom stock was up very big today. Also, remember, Robert Ford runs Abbott, and he runs it incredibly well. And I also think they’re going to settle these lawsuits or win the lawsuits that have really kept the lid on the stock, and that’s going to happen in 2025.”

Abbott Laboratories (NYSE:ABT) is a healthcare company that focuses on the research, development, manufacturing, and marketing of various medical products.

Overall, ABT ranks 4th on our list of stocks that Jim Cramer discussed recently. While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ABT but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.